These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1722962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prostatic specific antigen and prostatic pathology. Value of preoperative blood assay. Preliminary study apropos of 709 case reports].
    Bordes M, Brunet-Lecomte P, Dusserre P, Dusserre-Guion L, Michiels-Marzais D, Morlevat F, Peny J, Roignot P, Colas JM, Ferry N.
    Ann Urol (Paris); 1989; 23(4):295-300. PubMed ID: 2480077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 8. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP, Heyns CF, Zarrabi AD.
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [Abstract] [Full Text] [Related]

  • 9. PSA excess in the differential diagnosis of prostate carcinoma.
    Díaz F, Morell M, Rojo G.
    Arch Esp Urol; 1997 May; 50(4):415-8. PubMed ID: 9219422
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS, Heyns CF, Van Vuuren SP, Zarrabi AD.
    S Afr J Surg; 2012 Nov 12; 50(4):127-30. PubMed ID: 23217554
    [Abstract] [Full Text] [Related]

  • 13. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan 12; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen: a valuable clinical tool.
    Oesterling JE.
    Oncology (Williston Park); 1991 Apr 12; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 12; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 16. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT.
    Urology; 2009 Jul 12; 74(1):177-83. PubMed ID: 19428074
    [Abstract] [Full Text] [Related]

  • 17. Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer.
    Romppanen J, Haapalainen T, Punnonen K, Penttilä I.
    Anticancer Res; 2002 Jul 12; 22(1A):415-20. PubMed ID: 12017325
    [Abstract] [Full Text] [Related]

  • 18. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 19. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M, Kraljić I.
    Anticancer Res; 1997 Dec 15; 17(3A):1531-4. PubMed ID: 9179191
    [Abstract] [Full Text] [Related]

  • 20. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Dec 15; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.